• Gary Neville has criticised Mikel Arteta’s touch-line antics against Tottenham
• The Sky Sports pundit said the Arsenal boss should’ve shown more ‘composure’ 
• Mail Sport’s new WhatsApp Channel: Get the breaking news and exclusives here

By James Cohen For Mailonline

Published: 09:50 EDT, 25 September 2023 | Updated: 09:51 EDT, 25 September 2023

A record number of doctors applied to be certified to treat obesity this year amid the soaring popularity of weight-loss drugs like Ozempic and Wegovy.

Nearly 1,900 doctors signed up for the annual exam this October, the medical board behind the test said, which was a 50 percent increase compared to the previous year.

Passing the exam distinguishes doctors as competent in treating obese patients and could set them on A path to rake in higher salaries.

It comes after official data showed a record 40 percent of adults are now obese in three states — West Virginia, Louisiana and Oklahoma — while every state had seen a rise in rates compared to just a decade ago.

Weight loss drug prescriptions have surged in the US with five million written last year, up 2,000 percent in 2019. 

Analysts suggest this market will be worth $56billion by 2030, with doctors who have specialized in obesity medicine likely able to charge more to patients. 

Data from the American Board of Obesity Medicine revealed a record number of doctors had signed up to take the exam this year.

Back in 2012 — when the accreditation scheme was set up — barely 200 doctors applied.

Healthcare workers do not need the obesity certificate in order to treat obese patients, but it can make them more competent in caring for the patients. 

It can also serve as a stepping stone to doctors signing up for further training as bariatric surgeons — or a doctor who has specialized in performing weight loss surgeries such as a gastric bypass.

This would require another one to two years of training on top of the initial four required to become a doctor plus the three-to-seven-year residency.

Bariatric doctors earn about $450,000 per year on average, statistics suggest, compared to $412,000 for general surgeons. In some cases, they can be paid upward of $700,000.

The ABOM says doctors are expected to become certified by them in order to become a bariatric surgeon. 

Modules taught to doctors in the course look at the causes of the disease and how to help patients lose weight through diet changes and exercise.

They may also be taught about ‘pharmacotherapy’ for helping patients reduce their waistlines, which may include being taught about popular weight-loss drugs.

Dr Kimberly Gudzune, the medical director for the ABOM, told Insider: ‘As there’s more awareness of both obesity as a chronic disease and all of the effective treatment options, patients are coming into their physicians and saying: “I want to be treated”.

‘And I think that that is oftentimes the trigger for a lot of busy practitioners to say, “I really need to know how to do this”.’

She added: ‘We’re working to address that gap [on obesity knowledge among doctors].

‘But it does take time, and I think that the growth does speak to us working in that direction.’

There are more than one million doctors in the US, of which nearly 7,000 — or 0.007 percent — have the board certification to treat obesity.

The specialization is not needed in order to be allowed to treat obese patients, but it will give doctors advanced knowledge.

As well as their busy schedules, doctors will also need to complete at least 30 hours of lectures and another 30 of studying before taking the exam.

A gold rush is currently on among pharmaceutical giants to tap into the nascent weight-loss medications market.

Novo Nordisk — which is behind semaglutide used in Wegovy and Ozempic — raked in a record $5.5billion last year after investing in factories to manufacture the drug in the United States.

It is also behind a number of drugs for diabetes patients and some medicines for hemophilia patients.

Eli Lilly has also cashed in on the market with its obesity treatment tirzepatide, projected to make $48billion once approved.

Pfizer — which made billions with its Covid vaccine — is also developing its own class of weight-loss drugs in order to access the market.

To celebrate its 100th anniversary, The Walt Disney Company has opened its vaults to reveal a list of 30 locations across Europe, the Middle East and Africa that have inspired, and featured in, its films and theme parks over the past century.

These locations and productions are presented in a series of paired photographs, so fans can compare the real-world attractions with how they’ve been reinterpreted and used by Disney’s filmmakers and designers. 

Examples include the Norwegian fortress that partly inspired the castle in Frozen, the Tudor estate that influenced the maze in Alice in Wonderland and the enchanting forest that informed the setting for Snow White and the Seven Dwarfs. 

Research commissioned by The Walt Disney Company found that two in five (42 per cent) Brits are unaware that many Disney films and park attractions are based on real-world locations.

The study also found that when Brits were asked which UK locations they would like to see featured in future Disney films, the Lake District topped the list (14 per cent), followed by Loch Ness (10 per cent) and Edinburgh Castle (10 per cent).

Scroll down for all 30 pictures to see how incredible real-world places have had starring roles in Disney productions – and fired up the imaginations of its creative staff…

The rise of weight-loss drugs isn’t only shrinking Americans’ waistlines, it could also shrink food corporations’ bottom lines. 

Some experts predict junk food companies – already battling a rise in health conscious customers – could face a tobacco-like demise due to drugs like Ozempic and Wegovy, which reduce cravings and make people feel full longer. 

Big banks, such as Morgan Stanley, predict 24 million people, or seven percent of the US population, will be taking weight-loss drugs by 2035. 

An analysis by the bank also predicts patients prescribed the drugs will consume one-quarter of the candy, confectionary and other junk food they did before – slashing billions of dollars from annual revenue.

And corporations are already spooked. A recent analysis found executives at junk food companies are increasingly talking about the medications with investors. 

Morgan Stanley’s food analyst Pamela Kaufman said in a report: ‘The food, beverage and restaurant industries could see softer demand, particularly for unhealthier foods and high-fat, sweet and salty options.’ 

The new class of medications can lead to a 20 to 30 percent reduction in daily calories, and people tend to eat less high-sugar and high-fat foods, meaning the makers of chips, cookies and baked goods could take a hit, with banks predicting a drop in consumption by as much as three percent through 2035.

While any negative impacts are likely to be gradual, investors and c-suite executives have already begun to worry. 

Reuters’ Breakingviews scoured the transcripts of corporations’ presentations, events and earnings calls, which is a conference between the management of a company, financial analysts, media and investors.

It found in 2022, there were 18 mentions of Wegovy, Ozempic and Mounjaro. So far in 2023, at least one of these drugs was mentioned in calls 71 times.  

Morgan Stanley’s research found 73 percent of people on the weight loss drugs ate less confectionary food, which includes sugary candy, chocolate and some baked goods. 

Seventy percent of people consumed fewer sugary drinks; 69 percent ate less cookies; and 67 percent reached for fewer salty snacks. 

These drastic reductions could spell trouble for the mega-producers of these types of food, including Cadbury and Oreo producer Mondelez International, Nestle, which makes Hot Pockets and Häagen-Dazs, and Kraft Heinz, which produces products like Jell-O and Kraft Mac and Cheese. 

These companies dominate the global market for snacks, which is currently valued at half a trillion dollars, and they should brace for falling demand.

The hospitality industry is also taking a hit. The same survey found 77 percent of people on weight-loss drugs took fewer trips to fast-food establishments and 74 percent ate at pizzerias less. 

Like snack-makers, major players in the fast food industry, such as McDonald’s, Burger King and Yum Brands, which owns KFC and Taco Bell, could see falling demand, with analysts forecasting a drop in sales between one to two percent by 2035.

While two percent may not seem like a lot, it equates to nearly $7 billion.   

Alcohol will also take a hit from the rise in weight-loss prescriptions. Two-thirds of Americans on these medications report consuming less alcohol and nearly one-quarter stopped drinking alcohol altogether. 

Banking analysts projected US-focused alcohol companies face the highest risk and can expect a two percent decline in consumption by 2035. 

The implications of weight-loss drug approval and popularity extends beyond the food and beverage industries.

Financial analysts also predict companies that make products to treat conditions stemming from obesity could also take a hit.

Companies that manufacture products for sleep apnea, a condition in which sufferers intermittently stop breathing while asleep, will likely see a reduction in value because approximately 70 percent of sufferers are obese. 

Additionally, companies that sell joint replacements should also expect their valuations to decline. 

And rival weight-loss businesses, such as WW International, formerly known as Weight Watchers, has seen its shares plummet by about 70 percent since Wegovy was approved in June 2021. Jenny Craig, a similar business, shut down in May after more than 40 years because of growing competition from weight-loss drugs. 

The Department of Justice pulled a last-minute maneuver to block an FBI agent allegedly involved in Big Tech’s suppression of the Hunter Biden laptop story from testifying before Congress. 

The House Judiciary Committee is investigating whether Hunter Biden’s laptop was downplayed by social media companies. As part of the probe, Chairman Jim Jordan uncovered that an FBI agent involved in the saga – Elvis Chan – lied about the computer.

Chan had agreed to voluntarily appear Friday to provide the committee testimony and be represented by his personal counsel. 

Agency witnesses are allowed to bring either agency counsel or personal counsel to committee interviews, but not both. The rule is set up so agency witnesses can be more candid in testimony without fear of professional retribution, according to the committee.

But two sources with direct knowledge of the situation tell DailyMail.com that DOJ derailed the testimony because agency counsel also showed up Friday morning. As a result, Chan’s interview did not take place as planned.

Now, an official subpoena is expected to be issued later Friday for Chan to appear for a transcribed interview next Thursday, Sept. 21. 

The FBI disputed the claim that DOJ blocked Chan from testifying, calling it a ‘significant departure’ from normal procedures. And the DOJ said the committee blocked the interview, not them.

‘Today, after an FBI employee traveled across the country to voluntarily participate in a scheduled interview, he was denied the right to have his chosen legal counsel accompany him,’ an FBI spokesperson told DailyMail.com.

‘Upon arrival at the Capitol, Committee staff directed agency counsel to leave the premises, and the interview was unable to proceed. This is a significant departure from normal procedures and an unnecessary escalation of this Committee’s treatment of FBI officials. The FBI employee remains willing to take part in a voluntary interview with appropriate legal representation.’

‘The FBI recognizes the importance of congressional oversight and will continue to proceed in accordance with the long established accommodations process,’ the spokesperson continued.

The spokesperson also noted that more than a dozen other FBI employees have participated in interviews with the committee with no incident.

A Justice Department official told DailyMail.com that ‘DOJ did not block the interview, the Committee did.’

‘Agent Chan chose to be represented by both agency and personal counsel. He went to the Capitol this morning to testify and, instead of asking him questions, Committee staff turned him away and threatened to throw agency counsel out of the room.’ 

Last month, Jordan published excerpts of the testimony given by Chan, who served as one of the FBI’s liaisons with tech companies, and Laura Dehmlow, the current FBI section chief of the Foreign Influence Task Force.

Chan testified in November 2022 as part of Missouri and Louisiana‘s lawsuit against the federal government and the Biden administration for colluding with social media companies to censor speech.

Jordan said that Chan held a repeat meeting with Facebook about the laptop, but testified he had only had one session. He also testified that he was not aware of internal debate about the laptop, but told a colleague he was ‘up to speed.’

Dehmlow spoke to Jordan’s committee earlier this summer without incident. 

Jordan said that Dehmlow revealed how the FBI knew the laptop was not a forgery or plant, but refused to confirm its authenticity to social media companies. 

Jordan recently publicized internal Facebook documents have resulted in bombshell revelations about Hunter Biden’s laptop, arguing that it illustrated the FBI knew the laptop was authentic and belonged to him – but refused to confirm the fact to Facebook and Twitter.

That decision led to the New York Post’s report about the laptop being blocked by the social media companies, who labelled it as disinformation.

‘Internal FB docs reveal that an FBI Special Agent made false statements in testimony about the FBI’s role in the suppression of the Hunter Biden laptop story,’ tweeted Jordan last month.

Jordan explained in a Twitter thread how, on October 14, 2020, The New York Post published its first story about the laptop, which Biden had left behind in a Delaware repair shop.

The laptop contained damning pictures of Hunter doing drugs and enjoying the company of prostitutes. 

It also contained emails and massive amounts of information about his business dealings. 

On the day the Post published its story, Chan and Dehmlow met with representatives of Twitter and then Facebook.

Twitter’s team asked whether the FBI thought Hunter Biden’s laptop was real: one FBI representative replied yes, and then another quickly said: ‘No comment.’

Dehmlow told Jordan’s committee that there was then internal deliberations, and it was decided that the answer would be ‘no comment’ from then on.

At the next meeting, with Facebook, Dehmlow herself told Facebook ‘no comment’ when asked if the laptop was real.

‘It was an ongoing investigation, and we generally don’t comment on ongoing investigative matters when asked,’ she told Jordan’s committee.

Jordan on Monday declared: ‘Did Dehmlow know that the FBI had the laptop and it was real? Yes.

‘Did other key members of the FBI’s Foreign Influence Task Force know? Yes.

‘The FBI knew the laptop was real and yet decided it would say ‘no comment.’

‘We know what happened next.

‘Twitter and Facebook censored the @nypost story.

‘The Biden campaign secretly set in motion the events that led to the 51 former intel officials discrediting the story as Russian disinformation.’

Jordan and his allies are convinced that the FBI was working to discredit the story, in a bid to downplay it and help Joe Biden’s electoral chances.

Jordan then singled out extracts from Chan’s testimony at the end of last year.

Chan was asked by the Missouri and Louisiana officials whether he had been involved in any meetings after October 14 with Facebook, where the Hunter Biden laptop was discussed.

Chan replied that he did not believe so.

‘I was confident that I was not a party to any meeting with social media companies where Hunter Biden was discussed outside of the one incident that I told you about,’ said Chan.

However, Jordan said that his committee ‘recently obtained an internal Facebook document PROVING that Agent Chan had a secret ‘follow up’ call with Facebook about the Hunter Biden laptop story on October 15, just one day after the @nypost story and the first Facebook meeting!’

Jordan noted that Chan also claimed that he had ‘no internal knowledge of [the FBI’s] investigation’ involving Hunter Biden’s laptop, but according to internal Facebook documents told a colleague he was ‘up to speed on the current state of the matter within the FBI.’

Jordan added: ‘Is there any wonder why the Biden DOJ has so far stonewalled the Committee’s efforts to interview Agent Chan?’

The committee still plans to get to the bottom of the ‘lie’ when Chan sits down with them next week.  

Stunning portraits showcase the softer side of the Big Apple, with incredible images illustrating raw and remarkable moments from across New York.  

Photographer Phil Penman took to the city’s streets each day between 2019 and 2023 and captured a series of sensitive moments as the world stood still during the pandemic. 

His moving black-and-white pictures, published in his new book New York Street Diaries, give a glimpse at the calm and tranquil side of the city during lockdown. 

For more than three decades, Penman, who was born in Dorset, has been working as a professional photographer, boasting an extensive catalog, including his spellbinding images of Michael Jackson, Madonna, Jennifer Lopez or Bill Gates. 

Penman says he quickly grasped how important it was to document what was happening inside one of the world’s greatest cities at such a sensitive time. 

When tragedy struck New York on 11 September 2001, Penman was there with his camera documenting history as the terrifying scenes unraveled before his eyes.  

‘The Covid 19 pandemic was no different,’ Penman told DailyMail.com. ‘I knew that we were going through a life changing event. 

‘For me, my life as it was, started and ended on September 11th. I feel for a lot of us, it was the same during COVID 19. 

‘We were going through something the world had not seen for a long time. Hopefully something we will never have to bear witness to again.’ 

Each day he would head out early in the morning until late at night trying to take as many pictures as he could.

He says the pandemic taught him ‘just how much we all need each other’.

‘I would go out capturing the streets as I saw them. Gone was the hustle and bustle of the streets. Instead, we would see seagulls on 8th Avenue, or hear birds chirping, and the sounds of ambulance sirens in the background. Another loved one that had been taken away from us by the horrific Covid 19 virus.

‘Out of the shadows had come the homeless population. These were the people I would chat with day to day. No longer were they asking for money, but instead a mask or some food. Long had they relied on the food left out the back of the restaurants. This sadly no longer existed due to the restaurants being closed.

‘I remember walking one day down Broadway. I saw someone’s home being thrown into the back of a sanitation truck. Next to the truck stood the owner, a man wearing a jacket, that said “F**k Everything”.

‘I went up to this man and asked if I could photograph the jacket. He replied “Where are you from?” I said “England”. 

‘It turned out that we had grown up about 10 miles away from each other in the county of Dorset. Now we found each other in the middle of a pandemic lockdown chatting on the streets of New York.

‘It’s been rewarding to receive all the great message from people all around the world who have bought the book and how it means so much to them that this time period was captured.’

There was a freshness and energy in the Chelsea camp coming into the new season following their summer influx of youthful arrivals.

At the same time, though, there was also a caution behind the scenes, an intrigued apprehension about exactly what is possible this season.

That’s the thing about young players, who this version of Chelsea are boldly putting their faith in.

They come with a carefree exuberance that can change the mood and lift the sort of gloom that hung over the Stamford Bridge club after their last season to forget.

That sense of new energy, has been further fuelled by the arrival of Mauricio Pochettino, the personable and charismatic head coach whose coaching and staff have been described as ‘top’ by certain members of his squad.

Their welcoming and engaging approach has been appreciated and contributed to an improved vibe around the camp.

The amount of individual time Pochettino and his coaches have given has also been noted and received as a welcome bonus, especially by some younger players.

But there is also an unpredictability and inexperience that comes with youth hence the uncertainty about whether they can meet the demands, as Pochettino has reiterated, that Chelsea have to win and now.

During another summer of Chelsea churn, they said farewell to 10 players from last season’s squad aged 26 and over plus the younger quartet of Mason Mount, Kai Havertz, Christian Pulisic and Joao Felix who are not exactly short of know-how.

But they have not bought in a single player from the same category with 25 year-old trio Robert Sanchez, Christopher Nkunku, Axel Disasi their most senior arrivals.

Striker Deivid Washington, whose signing was confirmed yesterday, and goalkeeper Djordje Petrovic, who is expected to follow, continue the theme.

Their squad at West Ham last Sunday contained just three players over-26 – Thiago Silva, Ben Chilwell and Raheem Sterling.

Chelsea had the second youngest starting XI on match day two of the new season behind Arsenal and overall have had the fourth youngest average age so far.

Their two displays so far have highlighted the upside of Chelsea’s plan but also areas of concern.

There has certainly been a new look and feel to Chelsea – much-needed after last season – who dominated against both Liverpool and West Ham.

But there has also been a lack of cold ruthlessness at both ends that has led to costly mistakes and left them with just one point.

‘There are many positive things [about Chelsea’s approach],’ Pochettino insisted. ‘But another thing is we need to give time for them to perform.

‘Today we have a good balance because even the younger ones have experience like Enzo Fernandez, a World Cup champion, but of course the Premier League is different.’

Pochettino highlighting the Premier League factor was notable with Arsenal, title challengers against the odds, last season a natural comparison.

Arsenal’s players for their second game of last season had over 400 more Premier League appearances between them compared to Pochettino’s squad at West Ham last week.

Whether it is in England’s top flight or just generally Pochettino accepts there are times when more nous will be needed.

He said: ‘The first step is to play well or to buy the idea of the philosophy but the second step is the most difficult thing, playing well and competing at the same time.

‘This is another football. Set pieces or things like this. In that football you need some experienced players but I think we have a good balance and it’s only about improving this and for sure we are going to improve in this way.

‘I think we can [win now]. I really believe in the squad and the quality of the squad and now it is only the process and we need to wait [for] the process.

‘We are in a good way, only of course, if today we had four or six points [it would] help to be positive but we need to be positive because it’s the beginning.

‘We are going to win games and, yes, no doubt the quality is there, it’s only a matter of time.’

After highlighting summer signings such as Moises Caicedo, Romeo Lavia, Disasi and Sanchez, Pochettino added: ‘If we see the projection of these players, we expect the best from them, we should win every single game.

‘The way we are playing and the platform of the team gives us the opinion we are in a good way. It is only a matter of time until we put it altogether.’

Friday against Luton the pressure will be on and victory now is Chelsea’s only option.

It is a meeting between giants and minnows that brought back memories for Pochettino of his first ever managerial victory at the Nou Camp in February 2009.

He said: ‘I was taking with Roberto De Zerbi in pre-season – he’s a good friend – and I said to him: ‘I was at Southampton, at Espanyol and sometimes we face Real Madrid and it happened the same.

‘It’s the beauty of football. With Espanyol, we beat the dream team of Barcelona with Guardiola, with Messi, Xavi, Iniesta, Puyol and Co. Maybe it is similar: Luton and Chelsea compared to Espanyol and Barcelona. It was the first time a bottom team beat a top team. It was a little bit lucky! A little bit!

‘I was telling the players today in our team meeting that we need to match the desire of the Luton players.

‘If we match all this, their will and everything, afterwards for sure we presume we have better quality and we have to win. But if not and we don’t match them, the game can be crazy.’

Recalling what it took to stun Barca, Pochettino joked: ‘I can’t give the secrets to the Luton coach!’

But he added: ‘We were Espanyol, we said all we are going to do is try to win, don’t care about making mistakes, we need to be brave and everything.

‘Football is about belief, being together, fighting, no matter the quality you have. If you match this, all the qualities, then you win. If you don’t then the game is going to be over.’

Pat Bennett, 68, once rode horses as an equestrian, jogged daily and worked in human resources, until a rare illness robbed her of her ability to speak in 2012.

But help is on the way thanks to four baby-aspirin-sized sensors implanted in her brain, part of a clinical trial at Stanford University.

The chips have helped Bennett communicate her thoughts directly from her mind to a computer monitor at a record-breaking 62 words per minute — over three times faster than the technology’s previous best.

Cognitive scientists and medical researchers outside Stanford are impressed as well.

One, Professor Philip Sabes at the University of California, San Francisco, who studies brain-machine interfaces and co-founded Elon Musk’s Neuralink, described the new study as a ‘big breakthrough.’

‘The performance in this paper is already at a level which many people who cannot speak would want, if the device were ready,’ Sabes told MIT Technology Review earlier this year, as the new Stanford research was still clearing peer review.  

‘People are going to want this,’ Sabes said.

The news comes just a few months after the FDA granted approval to Musk’s Neuralink, permitting the company to initiate human trials for its own competing brain-chip implant technology.

The Stanford results also follow efforts by the United Nations’ agency for science and culture (UNESCO) to develop proposals for how to regulate brain chip technology, which they worry could be abused for ‘neurosurveillance’ or even ‘forced re-education,’ threatening human rights worldwide.

For Bennett, however, this emerging research has been closer to miraculous than dystopian.

Since 2012, Bennett has struggled with amyotrophic lateral sclerosis (ALS), the same disease that took the life of Sandra Bullock’s partner Bryan Randall earlier this summer and famed physicist Stephen Hawking in 2018.  

Over the course of 26 sessions, each lasting about four hours, Bennett worked with an artificial-intelligence algorithm, helping to train the AI in how to identify which brain activity corresponds to 39 key phonemes, or sounds, used in spoken English.

Via the brain-sensor tech, which the Stanford researchers call an intracortical brain-computer interface (iBCI), Bennett would attempt to effectively communicate approximately 260 to 480 sentences per training session to the AI. 

The sentences were selected randomly from a large data set, SWITCHBOARD, sourced from a collection of telephone conversations collected by calculator-maker Texas Instruments for language research back in the 1990s.

The casual sentences included examples like, ‘I left right in the middle of it,’ and ‘It’s only been that way in the last five years.’

During sessions where the sentence options were held down to a 50-word vocabulary, Bennett and the Stanford team working with her were able to get the AI translator’s error rate down to 9.1 percent. 

When the vocabulary limit was expanded to 125,000 words, closer to the total number of English words in common use, the iCBI’s intended-speech AI had an uptick in its translation errors. The rate rose to 23.8 percent.  

While that error-rate leaves something to be desired, the researchers believed improvements could continue with more training and a wider interface, more implants in other words, interacting between the brain and the iBCI’s AI.

Already, the algorithm’s speed decoding thoughts to speech has bested all previous models three times over.  

The Stanford group’s iBCI was able to move at 62 words per minute, 3.4 times faster than the prior record-holder, and closer than ever to the natural rate of human conversation, 160 words per minute.

‘We’ve shown you can decode intended speech by recording activity from a very small area on the brain’s surface,’ according to Dr. Jaimie Henderson, the surgeon who performed the delicate installation of the iBCI electrodes onto the surface of Bennett’s brain.

Bennett, herself, personally testified to her own experience with the breakthrough results, writing via email that, ‘These initial results have proven the concept, and eventually technology will catch up to make it easily accessible to people who cannot speak.’ 

‘For those who are nonverbal, this means they can stay connected to the bigger world,’ Bennett wrote in an email supplied by Stanford, ‘perhaps continue to work, maintain friends and family relationships.’

Bennett had been diagnosed with amyotrophic lateral sclerosis (ALS), a neurodegenerative disease, over a decade ago.

ALS attacks the neurons in the body’s central nervous system that control movement, but Bennett’s own experience with the ailment was a particularly rare variety of the disease.

‘When you think of ALS, you think of arm and leg impact,’ Bennett said. ‘But in a group of ALS patients, it begins with speech difficulties. I am unable to speak.’

Dr. Henderson and his co-authors published the results of their work with Bennett in Nature this Wednesday.

Fishing firm Angling Direct reels in big sales

By Daily Mail City & Finance Reporter

Updated: 18:02 EDT, 23 August 2023

Some links in this article may be affiliate links. If you click on them we may earn a small commission. That helps us fund This Is Money, and keep it free to use. We do not write articles to promote products. We do not allow any commercial relationship to affect our editorial independence.

Former Matilda claims Sam Kerr made two big mistakes in World Cup defeat by England after Australia captain went from hero to zero following stunning semi-final strike

By Ollie Lewis For Daily Mail Australia

Published: 10:08 EDT, 16 August 2023 | Updated: 20:46 EDT, 16 August 2023